Back

Classification of ovarian cancer cell lines using transcriptional profiles defines the five major pathological subtypes

Barnes, B.; Nelson, L.; Tighe, A.; Morgan, R.; McGrail, J.; Taylor, S. S.

2020-07-15 cancer biology
10.1101/2020.07.14.202457 bioRxiv
Show abstract

Epithelial ovarian cancer (EOC) is a heterogenous disease consisting of five major pathologically distinct subtypes: High-grade serous ovarian carcinoma (HGSOC), low-grade serous (LGS), endometrioid, clear cell and mucinous carcinoma. Although HGSOC is the most prevalent subtype, representing approximately 75% of cases, a 2013 landmark study from Domcke et al., found that many frequently used ovarian cancer cell lines were not genetically representative of HGSOC tissue samples from The Cancer Genome Atlas. Although this work subsequently identified several rarely used cell lines to be highly suitable as HGSOC models, cell line selection for ovarian cancer research does not appear to have altered substantially in recent years. Here, we find that application of non-negative matrix factorisation (NMF) to the transcriptional profiles of 45 commonly used ovarian cancer cell lines exquisitely clusters them into five distinct classes, representative of the five main subtypes of EOC. This methodology was in strong agreement with Domcke et al., in identification of cell lines most representative of HGSOC. Furthermore, this robust classification of cell lines, including some previously not annotated or miss-annotated in the literature, now informs selection of the most appropriate models for all five pathological subtypes of ovarian cancer. Furthermore, using machine learning algorithms trained using the classification of the current cell lines, we are able provide a methodology for future classification of novel EOC cell lines.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Cancers
213 papers in training set
Top 0.3%
11.8%
2
Frontiers in Bioinformatics
49 papers in training set
Top 0.1%
10.9%
3
British Journal of Cancer
49 papers in training set
Top 0.2%
5.4%
4
PeerJ
308 papers in training set
Top 0.9%
5.4%
5
Scientific Reports
3612 papers in training set
Top 19%
5.1%
6
PLOS ONE
5266 papers in training set
Top 31%
4.8%
7
Cancer Research Communications
51 papers in training set
Top 0.4%
3.2%
8
eLife
5828 papers in training set
Top 38%
2.8%
9
The Journal of Pathology
26 papers in training set
Top 0.2%
2.6%
50% of probability mass above
10
Frontiers in Oncology
103 papers in training set
Top 2%
2.4%
11
Molecular Oncology
55 papers in training set
Top 0.5%
2.1%
12
iScience
1154 papers in training set
Top 15%
1.9%
13
Bioinformatics Advances
203 papers in training set
Top 3%
1.7%
14
Frontiers in Genetics
230 papers in training set
Top 3%
1.7%
15
Modern Pathology
22 papers in training set
Top 0.2%
1.7%
16
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.7%
17
International Journal of Molecular Sciences
494 papers in training set
Top 8%
1.7%
18
Computational and Structural Biotechnology Journal
242 papers in training set
Top 4%
1.5%
19
Bioinformatics
1204 papers in training set
Top 7%
1.5%
20
Heliyon
152 papers in training set
Top 4%
1.3%
21
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 3%
1.3%
22
BMC Cancer
67 papers in training set
Top 2%
1.0%
23
Frontiers in Immunology
638 papers in training set
Top 9%
1.0%
24
Frontiers in Molecular Biosciences
102 papers in training set
Top 2%
1.0%
25
Matrix Biology Plus
10 papers in training set
Top 0.2%
0.8%
26
Breast Cancer Research
36 papers in training set
Top 0.6%
0.8%
27
Communications Medicine
113 papers in training set
Top 5%
0.8%
28
Cells
249 papers in training set
Top 7%
0.8%
29
Open Biology
106 papers in training set
Top 2%
0.8%
30
Computational Biology and Chemistry
28 papers in training set
Top 1%
0.8%